GANGAGEN
GangaGen, Inc. is a clinical-stage biotechnology company focused on developing novel therapeutic proteins targeting infectious diseases in areas of high unmet need such as MRSA and other drug resistant bacteria. Using a proprietary platform, GangaGen is developing highly-specific therapeutic proteins called ectolysins to target clinically meaningful types of bacteria. The company’s lead ectolysin, P128, is a recombinant protein that binds to and kills Staphylococcus, including methicillin-resistant strains of S. aureus (MRSA).
GANGAGEN
Social Links:
Industry:
Biotechnology
Founded:
2000-01-01
Address:
Bangalore, Karnataka, India
Country:
India
Website Url:
http://www.gangagen.com
Total Employee:
11+
Status:
Active
Contact:
+1-650-8569642
Email Addresses:
[email protected]
Total Funding:
2.5 M USD
Similar Organizations
Avistone Pharmaceuticals
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
ConserV Bioscience
ConserV Bioscience is a clinical-stage biotechnology company focused on developing vaccines.
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - GangaGen
Official Site Inspections
http://www.gangagen.com
- Host name: 17.51.180.107.host.secureserver.net
- IP address: 107.180.51.17
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
